Liquid-based cytology with HPV triage of low-grade cytological abnormalities versus conventional cytology in cervical cancer screening

Current Pharmaceutical Design

Volumn 19, Issue 8, 2013, Pages 1406-1411

  Fröberg, Maria ^a   Norman, Ingrid ^a   Johansson, Bo ^a   Hjerpe, Anders ^a   Weiderpass, Elisabete ^b,c,d,e   Andersson, Sonia ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d UNIVERSITY OF TROMSØ   (Norway)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cervical intraepithelial neoplasia (CIN); Human papillomavirus; Liquid based cytology; Screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COLPOSCOPY; CYTOLOGY; CYTOPATHOLOGY; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TRIAGE; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

EID: 84876725058     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161213804805603     Document Type: Article

References (21)

1. IARC. IARC handbooks of cancer prevention. Volume 10: Cervix cancer screening. Lyon: International Agency for Research on Cancer 2005.
2. Jordan J, Arbyn M, Martin-Hirsch P, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008; 19: 342-54.
3. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 2008; 111: 167-77.
4. Ronco G, Cuzick J, Pierotti P, et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 2007; 335: 1-7.
5. Siebers AG, Klinkhamer PJ, Grefte JM, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA 2009; 302: 1757-64.
6. Strander B, Andersson-Ellstrom A, Milsom I, Radberg T, Ryd W. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program: a prospective randomized study. Cancer 2007; 111: 285-91.
7. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004; 96: 280-93.
8. Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006; 24(Suppl 3): S78-89.
9. Fröberg M, Johansson B, Hjerpe A, Andersson S. Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities. Br J Cancer 2008; 99: 563-8.
10. Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J. Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate. J Cell Mol Med 2009; 13: 648-59.
11. Arbyn M, Herbert A, Schenck U, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology 2007; 18: 133-9.
12. Zhu J, Norman I, Elfgren K, Gaberi V, Hagmar B, Hjerpe A, Andersson S. Acomparison of liquid-based cytology and Pap smear as a screening method for cervical cancer. Oncol Rep 2007; 18: 157-60.
13. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
14. Muñoz N, Castellsagué X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24 (Suppl 3): S1-10.
15. Confortini M, Bergeron C, Desai M, et al. Accuracy of liquidbased cytology: comparison of the results obtained within a randomized controlled trial (the New Technologies for Cervical Cancer Screening Study) and an external group of experts. Cancer Cytopathol 2010; 118: 203-8.
16. Dillner L, Kemetli L, Elfgren K, et al. Randomized healthservices study of human papillomavirus-based management of low-grade cytological abnormalities. Int J Cancer 2011; 129: 151-9.
17. Bulkmans NW, Berkhof J, Rozendaal L, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-72.
18. Leinonen M, Nieminen P, Kotaniemi-Talonen L, et al. Agespecific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting. J Natl Cancer Inst 2009; 101: 1612-23.
19. Naucler P, Ryd W, Tornberg S, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007; 357: 1589-97.
20. Ronco G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010; 11: 249-57.
21. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med 2009; 360: 1385-94.